Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.11.17.624006

Small form factor implantable neural probe with efficient flip chip micro LED for in vivo optogenetics

Abrantes, M.·Pereira, T.·Silva, P.·Falcao, M.·Borme, J.·Alpuim, P.·Jacinto, L.
View original source ↗Export metadata ↓

Abstract

Optogenetics is a widely used tool to dissect neural circuits with optical stimulation, but it requires that light is delivered to photosensitive neurons inside the brain. Implantable neural probes with microscale LEDs (LEDs) are an emerging approach to delivering light to the brain with superior light output control. However, approaches to integrate LEDs in neural probes depend on complex fabrication processes. Here, we developed an implantable small form factor neural probe that integrates highly efficient commercial flip chip LEDs using only standard lithography processes in silicon and a custom automated LED mounting approach with custom 3D-printed tools on a pick-and-place machine. The probe has a cross-sectional area under 0.013 mm2 but can output up to 2.5 mW of optical power with an irradiance of 175 mW/mm2. Due to the high plug efficiency of the LED, the neural probe can perform stimulation protocols up to 20 Hz and 80% duty cycles without surpassing estimated hotspot temperature elevations above 1 {o}C. The neural probes were validated in vivo, with brain activity in the motor cortex of transgenic mice being reliably modulated by pulsed light emitted from the probe.

Source connections

Explore related subjects

bioengineeringPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Abrantes, M., Pereira, T., Silva, P., Falcao, M., Borme, J., Alpuim, P., Jacinto, L.. 2024-11-18. Small form factor implantable neural probe with efficient flip chip micro LED for in vivo optogenetics. https://doi.org/10.1101/2024.11.17.624006

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Proprietary Processing of Placental Tissue Allografts Influences Wound Healing Trajectories in a Rodent Excisional Skin Wound Model

Introduction: Placental tissue allografts are widely utilized in the management of chronic wounds, including diabetic foot ulcers. In addition to serving as wound coverings, these products may influence wound repair through extracellular matrix architecture and biologically active signaling molecules native to human amniotic tissue. Manufacturing and processing methodologies vary considerably across commercially available products and may substantially impact biologic activity, tissue remodeling, and wound-healing trajectories. In this study, a rodent wound-healing model was utilized to compare a proprietary processed placental tissue allograft with a conventionally processed placental tissue comparator. Methods: Two arms of a five-arm pilot rodent wound-healing study were evaluated to compare a proprietary processed human amniotic tissue allograft against a conventionally processed comparator; the remaining arms evaluated test articles under development and will be reported separately. Male rats (n=8 per arm), matched for weight, age, and diet, each received two full-thickness dorsal excisional wounds approximately 10 mm in diameter and 2 mm deep. Test articles were reapplied upon resorption over a 14-day period. At Day 14, sections were scored semi-quantitatively (0-4 Severity Injury Score) across histologic and immunohistochemical parameters spanning epidermal repair, inflammation, angiogenesis, proliferation, and remodeling. Cranial and caudal wounds were averaged within each animal, retaining the animal as the experimental unit. A Day 14 Histology Resolution Score was derived as a signed composite of pro- and anti-regenerative markers and evaluated alongside percent wound closure. Inferential statistics (Welch ANOVA with Games-Howell post hoc) were derived from the full five-arm cohort (n=40). Results: Animals treated with the proprietary processed allograft showed more advanced progression toward wound resolution than those receiving the conventionally processed comparator, across both surface and tissue-level endpoints. Mean animal-level wound closure at Day 14 was 95.2% with the proprietary processed allograft versus 89.9% with the conventional comparator. The integrated Day 14 Histology Resolution Score, a composite of epidermal repair, inflammation, angiogenesis, proliferation, and remodeling endpoints was 8.94 versus 5.13, corresponding to a shift from the poor-resolution range into the partial-resolution range on the pre-defined interpretive scale. Welch ANOVA across the full five-arm cohort (n=40) detected a significant overall effect of treatment on this composite (p = 0.010). The pairwise contrast between these two arms did not reach significance under Games-Howell correction across ten comparisons (p = 0.337); at n=8 per arm the study was not powered to resolve individual pairwise differences, and the observed standardized difference was large (Hedges' g = 0.93). Injury endpoints were consistently lower in the proprietary processed allograft: 69% lower acute inflammation, 60% lower dermal necrosis, approximately 57% lower epithelial erosion, 46% lower ulceration, and 42% less hemorrhage. Importantly, these reductions in residual tissue injury occurred while maintaining robust granulation tissue formation, angiogenesis, collagen remodeling, cellular proliferation, and macrophage recruitment. Discussion: These findings suggest that processing methodologies can materially influence the biologic performance of placental tissue allografts. The proprietary processed allograft was associated with lower residual tissue injury and greater regenerative and reparative activity relative to a conventionally processed comparator. These observations support the concept that placental tissue allografts should not necessarily be viewed as biologically equivalent and may have important implications for clinical outcomes and product selection in wound care.

bioengineering↗
bioRxiv2026

Click alginate cryogel for real-time gastric pH monitoring

Gastric acidity shapes mucosal injury in reflux disease, peptic ulcer, and gastritis, yet is almost never measured. Acid-suppressive therapy, taken by approximately 40% of elderly adults, is therefore titrated on symptoms alone. A gastric sensor must hold onto its reporter in a highly acidic protease-rich environment, conditions that destabilize ionically crosslinked hydrogels and leach physically entrapped dyes. Click alginates, established in biomechanics and drug delivery but not as sensors, meet this requirement with a single chemistry: bioorthogonal tetrazine-norbornene crosslinks are inert to acid and proteases, and excess norbornene from crosslinking become the anchoring site for the pH-sensitive reporter, so network and reporter are installed by the same mechanism. Cryogelation adds macroporosity for rapid gastric fluid influx. A screen identifies IRDye 680RD as the only near-infrared dye responsive across the targeted pH 2-5. Dye release stays below 1.5% in simulated gastric and intestinal fluids, and the pH response remains active after nine months of storage. In rats, the orally administered NIR fluorescent cryogel resolves pH 2.0 from pH 5.0 transabdominally, and discriminates esomeprazole- from saline-treated animals, without plasma fluorescence. Photoacoustic imaging points toward detection at translationally relevant depths, establishing covalently functionalized cryogels as a general sensing platform for hostile physiological environments.

bioengineering↗
bioRxiv2026

Curved by Design: Applying Microfluidic Principles for Nonplanar and Planar Suspended Tissue Patterning to the Development of Bladder Models with Tunable Mechanics

Cells in vivo exist in a complex environment where they receive chemical and physical cues from neighboring cells and the extracellular matrix. Suspended, three dimensional (3D) cell culture enables the study of mechanical signals in a controlled in vitro setting where cells can exert forces on the extracellular matrix, and mechanical stimulation can be externally applied. In addition to mechanical cues, tissues in vivo also exhibit spatial heterogeneity and nonplanar topography. To facilitate the development of suspended 3D cell culture models with both spatial and geometric complexity, we previously introduced Suspended Tissue Engineering with Assemblable Microfluidics (STEAM). STEAM is an accessible, modular platform that utilizes fluidic patterning to create multiregional planar and nonplanar suspended cell-embedded 3D tissues. Herein, we further characterize the STEAM dome platform by developing a theoretical model that explains some experimental considerations necessary for successful two-region patterning in a nonplanar construct. We highlight a brief biological application of the planar and nonplanar STEAM platforms by creating simple but physiologically relevant model systems for the bladder, a sphere-like organ with concentric tissue layers and a central lumen that dynamically expands and contracts during filling and voiding. We demonstrate that the suspended configuration of the planar bladder smooth muscle tissue patch induces inherent tension, which can be increased by further straining the tissues; both result in muscle cell alignment along the axis of stretch as shown by a clear peak at 90 degrees in a radial sum analysis of the two dimensional Fast Fourier Transform of images with fluorescent signal from myosin heavy chain 11 immunostaining. Further, we utilize the nonplanar STEAM platform with a human urothelial cell line (HBLAK) and primary bladder smooth muscle cells (HBdSMC) to create a bladder wall model, resulting in a domed, bilayered tissue. STEAM integrates patterning precision, mechanical functionality, and customizability to actualize an accessible and low cost alternative to generate spatially and geometrically complex suspended tissues.

bioengineering↗